Beta‐blockers improve survival outcomes in patients with multiple myeloma: a retrospective evaluation

A preclinical study demonstrated anti‐proliferative and apoptotic effect of propranolol on multiple myeloma (MM) cell. Clinical studies suggested that beta‐blocker (BB) might impact the prognosis of breast, prostate, colorectal, ovarian, lung, and skin cancer. This retrospective study evaluated the...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Am J Hematol
Asıl Yazarlar: Hwa, Yi L., Shi, Qian, Kumar, Shaji K., Lacy, Martha Q., Gertz, Morie A., Kapoor, Prashant, Buadi, Francis K., Leung, Nelson, Dingli, David, Go, Ronald S., Hayman, Suzanne R., Gonsalves, Wilson I., Russell, Stephen, Lust, John A., Lin, Yi, Rajkumar, S. Vincent, Dispenzieri, Angela
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2016
Konular:
Research Articles
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5217079/
https://ncbi.nlm.nih.gov/pubmed/27733010
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/ajh.24582
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller